This paper will briefly review conventional (ie. non-molecular) techniques for the laboratory diagnosis of tuberculosis; the use of molecular technology in laboratory diagnosis will be dealt with elsewhere, as will the problems of applying diagnostic facilities in developing countries.
Get full access to this article
View all access options for this article.
References
1.
BishopB J, NewmannO. The history of the Ziehl-Neelsen stain. Tubercle1970; 51: 196–206.
2.
WattB, RaynerA, HarrisGModern methods in mycobacteriology. Rev Med Microbiol1993; 4: 97–105.
3.
SaceanuC A, PfeifferN C, McLeanT.Evaluation of sputum smears concentrated by cytocentrifugation for detection of acid-fast bacilli J Clin Microbiol1993; 31: 2371–2374.
4.
McCarterY S, RobinsonA.Detection of acid-fast bacilli in concentrated primary specimen smears stained with rhodamine-auramine at room temperature and at 37°C. J Clin Microbiol1994; 32: 2487–2489.
5.
International Union Against Tuberculosis. Year Book1955: 89.
6.
MejiaG I, CastrillonL, TrujiilioHMicrocolony detection in 7HII thin layer culture is an alternative for rapid diganosis of Mycobacterium tuberculosis infection. Int J Tub Lung Dis1999; 3: 138–142.
7.
MiddlebrookG, RaggiardoZ, TigettW.Automated radiometric detection of growth of Mycobacterium tuberculosis in selected media. Am Rev Respir Dis1977115: 1066–1069.
8.
MageeJ G, FreemanR, BarrettA.Enhanced speed and sensitivity in the cultural diagnosis of pulmonary tuberculosis with a continuous automated mycobacterial liquid culture (CAMLiC) system. J Clin Microbiol1998; 47: 547–553.
9.
StyrtB A, ShinnickT M, RidderhofJ CTurnaround times for mycobacterial cultures. J Clin Microbiol1997; 35: 1041–1042.
10.
JenkinsP A, PattynS R, PortaelsF.Diagnostic bacteriology in: RattedgeCStanfordJ, eds. The Biology of the Mycobacteria, London Academic Press1982; 454–470.
11.
LeatJ L, MarksJ.Improvement on drug-sensitivity tests on tubercle bacilli. Tubercle1970; 51: 68–73.
12.
HeifetsL B. Drug susceptibility in the chemotherapy of mycobacterial infections. Boca Raton, Ann Arbor, Boston, London: CRC Press1991;pp 99–101.
13.
WilsonS M, Al-SuwaidiZ, McNerneyREvaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nature Med1997; 3: 465–468.
14.
DrowartA, CambiasoC L, HugyenK.Detection of rifampicin and isoniazid resistance of Mycobacterium tuberculosis strains by particle counting immunoassay (PACIA). Int Tub Lung Dis1997; 1: 284–288.
15.
CookseyR C, CrawfordJ T, JacobsW RA rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob Agents Chemother1993; 37: 1348–1352.
16.
MeredithS, WatsonJ M, CitronK MAre healthcare workers in England and Wales at increased risk of tuberculosis?Br Med J1996; 313: 522–525.
17.
Categorisation of biological agents according to hazards and categories of containment. Advisory Committee on Dangerous Pathogens, Fourth Edition (Supplement 1998). HSE Books1995.
18.
DrobniewskiF A, WilsonS M. New biomedical assays must be tested by direct study in the developing world. Br Med J1998; 316: 940.
